Shares of Intra-Cellular Therapies are surging 35% in premarket trading Monday after Johnson & Johnson said it will acquire ...
Dealbreaker on MSN2h
J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular TherapiesJohnson & Johnson, already a big player in neuroscience drugs, is adding to its portfolio and pipeline with a deal to acquire ...
1don MSN
Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by ...
Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...
Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion. The biggest driver was the rights Caplyta which has ...
AST SpaceMobile secured the spectrum from Ligado Networks after it filed for bankruptcy. It means AST can offer cellular ...
NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...
Study from neutral host providers discovers how Wi-Fi and cellular connectivity have overtaken traditional priorities like price and amenities as top considerations for businesses choosing commercial ...
Nokia has announced that it has reached the milestone of 7,000 patent families declared as essential to 5G with more to ...
Time-restricted eating, particularly among people with underlying metabolic disorders, may confer benefits beyond weight loss ...
The Honeywell-Verizon bundled solution is designed to meet the unique needs of retail and logistics companies of all sizes and will provide a range of benefits, including: Simplified Procurement: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback